Nebulized ketamine for moderate to severe asthma attacks
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests whether adding a nebulized (breathing mist) form of ketamine to usual asthma care helps people having a moderate to severe asthma attack in the emergency room. It aims to see if this combination works better than usual care alone for opening up your airways and easing breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a moderate to severe asthma attack (not mild).
- Your peak flow reading is between 33% and 75% of your expected best.
- You are not pregnant or breastfeeding.
- You don't have certain other serious health conditions like unstable heart problems, untreated high blood pressure, or a history of psychosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if adding ketamine (a medicine given through a nebulizer) to standard care helps children ages 1 to 13 who are having a severe asthma attack. If it works, it could help them recover faster.
This trial tests if a ketamine mist you breathe in can help treat moderate to severe depression. It is for adults who are not helped enough by other treatments.
This study tests whether adding ketamine to sedation medications helps patients recover better after they no longer need a breathing machine in the hospital. Researchers want to see if it reduces confusion and speeds up healing.
This trial tests if a single dose of ketamine can quickly reduce suicidal thoughts in people who come to the emergency department. If you are having active suicidal thoughts and need inpatient care, you may be able to join.
This study tests if ketamine is a better sedative than other medicines for patients on a breathing machine in the ICU. If you are currently sedated but not with ketamine, you may be able to join.
This study tests whether ketamine plus a structured crisis-response plan can help reduce suicidal thoughts for adults admitted from the ER. It also aims to make care in the emergency setting more consistent and effective.
Hear when a new Asthma Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.